PG (NYSE: PG) grooming CEO exercises 36,093 options and sells 36,093 shares
Rhea-AI Filing Summary
Procter & Gamble CEO – Grooming Gary A. Coombe reported multiple equity transactions in Procter & Gamble common stock. On February 12, 2026, he exercised stock options for 36,093 shares at an exercise price of $78.52 per share, receiving the same number of common shares.
On the same date, he then sold 36,093 common shares in open-market transactions at a weighted average price of $162.3307, leaving 34,993.7893 shares of directly held common stock. He also reports indirect holdings of 486.4342 shares through a retirement plan trustee and 1,295.35 shares through an international stock ownership and pension plan.
In addition, previously granted restricted stock units, including 63.6893 units awarded on November 17, 2025, total 1,117.3663 RSUs. Footnotes explain that these RSUs and some share totals include dividend equivalents and may be delivered in shares upon retirement under the company’s programs.
Positive
- None.
Negative
- None.
Insights
Routine option exercise and same‑day sale by a P&G business unit CEO.
Gary A. Coombe, CEO – Grooming at Procter & Gamble, exercised stock options for 36,093 shares at an exercise price of $78.52 and received the same number of common shares. This is labeled as an exercise or conversion of a derivative security.
He then sold 36,093 common shares in open-market transactions at a weighted average price of $162.3307, leaving 34,993.7893 shares directly owned, plus smaller indirect plan holdings. The filing also notes 1,117.3663 restricted stock units, including 63.6893 units granted on November 17, 2025, which represent contingent rights to common stock.
These transactions are typical of equity compensation usage, where options are exercised and shares are sold to monetize awards. The filing does not provide comparative context to prior holdings or compensation structure, so the overall impact on his economic exposure to P&G will depend on future equity grants and any additional transactions reported in later filings.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 36,093 | $0.00 | -- |
| Exercise | Common Stock | 36,093 | $78.52 | $2.83M |
| Sale | Common Stock | 36,093 | $162.3307 | $5.86M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| Grant/Award | Restricted Stock Units | 63.689 | $0.00 | -- |
Footnotes (1)
- Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan. Weighted average price of the shares sold. The price range was $162.33 to $162.35. Full information regarding the number of shares sold at each separate price available upon request. Reflects adjustment to PST through December 31, 2025. Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.
